648 related articles for article (PubMed ID: 27313992)
1. Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis.
Bastos LM; Macêdo AG; Silva MV; Santiago FM; Ramos EL; Santos FA; Pirovani CP; Goulart LR; Mineo TW; Mineo JR
Front Cell Infect Microbiol; 2016; 6():59. PubMed ID: 27313992
[TBL] [Abstract][Full Text] [Related]
2. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
[TBL] [Abstract][Full Text] [Related]
3. C57BL/6 mice immunized with synthetic peptides from Toxoplasma gondii surface and microneme immunodominant antigens are able to decrease parasite burden in the brain tissues.
Barros HLS; Santana SS; Pajuaba ACAM; da Silva Cardoso Barros P; Dos Reis de Carvalho F; de Paiva VF; Wilson Patriarca Mineo T; Mineo JR
Acta Trop; 2019 Aug; 196():1-6. PubMed ID: 31059707
[TBL] [Abstract][Full Text] [Related]
4. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
Xue M; He S; Cui Y; Yao Y; Wang H
Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Protective Immune Response Induced by a DNA Vaccine Encoding GRA8 against Acute Toxoplasmosis in a Murine Model.
Chu JQ; Huang S; Ye W; Fan XY; Huang R; Ye SC; Yu CY; Wu WY; Zhou Y; Zhou W; Lee YH; Quan JH
Korean J Parasitol; 2018 Aug; 56(4):325-334. PubMed ID: 30196664
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice.
Zhu WN; Wang JL; Chen K; Yue DM; Zhang XX; Huang SY; Zhu XQ
Exp Parasitol; 2017 Aug; 179():20-27. PubMed ID: 28625894
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of
Guo J; Zhou A; Sun X; Sha W; Ai K; Pan G; Zhou C; Zhou H; Cong H; He S
Front Immunol; 2019; 10():592. PubMed ID: 30984177
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Protective Effect of Deoxyribonucleic Acid Vaccines Encoding Granule Antigen 2 and 5 Against Acute Toxoplasmosis in BALB/c Mice.
Ching XT; Fong MY; Lau YL
Am J Trop Med Hyg; 2017 Jun; 96(6):1441-1447. PubMed ID: 28719288
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice.
Liu S; Shi L; Cheng YB; Fan GX; Ren HX; Yuan YK
Parasitol Res; 2009 Jul; 105(1):267-74. PubMed ID: 19288132
[TBL] [Abstract][Full Text] [Related]
11. T cell clones raised from chronically infected healthy humans by stimulation with Toxoplasma gondii excretory-secretory antigens cross-react with live tachyzoites: characterization of the fine antigenic specificity of the clones and implications for vaccine development.
Prigione I; Facchetti P; Lecordier L; Deslée D; Chiesa S; Cesbron-Delauw MF; Pistoia V
J Immunol; 2000 Apr; 164(7):3741-8. PubMed ID: 10725733
[TBL] [Abstract][Full Text] [Related]
12. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
Zheng B; Lu S; Tong Q; Kong Q; Lou D
Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
[TBL] [Abstract][Full Text] [Related]
13. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.
Golkar M; Shokrgozar MA; Rafati S; Musset K; Assmar M; Sadaie R; Cesbron-Delauw MF; Mercier C
Vaccine; 2007 May; 25(21):4301-11. PubMed ID: 17418457
[TBL] [Abstract][Full Text] [Related]
15. Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant.
Zhou H; Min J; Zhao Q; Gu Q; Cong H; Li Y; He S
Vaccine; 2012 Feb; 30(10):1800-6. PubMed ID: 22240340
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity induced by peptides of AMA1, RON2 and RON4 containing T-and B-cell epitopes via an intranasal route against toxoplasmosis in mice.
Zhang TE; Yin LT; Li RH; Wang HL; Meng XL; Yin GR
Parasit Vectors; 2015 Jan; 8():15. PubMed ID: 25582167
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the immune response in BALB/c mice induced by a novel DNA vaccine expressing GRA14 against Toxoplasma gondii.
Ahmadpour E; Sarvi S; Hashemi Soteh MB; Sharif M; Rahimi MT; Valadan R; Tehrani M; Khalilian A; Montazeri M; Daryani A
Parasite Immunol; 2017 Apr; 39(4):. PubMed ID: 28186325
[TBL] [Abstract][Full Text] [Related]
18. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
[TBL] [Abstract][Full Text] [Related]
19. Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis.
Zhao G; Zhou A; Lv G; Meng M; Sun M; Bai Y; Han Y; Wang L; Zhou H; Cong H; Zhao Q; Zhu XQ; He S
BMC Infect Dis; 2013 May; 13():207. PubMed ID: 23651838
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
